Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy
Status:
Terminated
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the analgesic efficacy of two dose levels
of DEX-IN compared with placebo, using the summed pain intensity difference over the first 48
hours (SPID48) in subjects with acute moderate to severe pain following unilateral
bunionectomy.